ABL Bio Inc
KOSDAQ:298380
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
KR |
|
M
|
Massivit 3D Printing Technologies Ltd
TASE:MSVT
|
IL |
Intrinsic Value
The intrinsic value of ABL Bio Inc (298380) under the Base Case is 26 179.15 KRW per share. Compared with the current market price of 44 250 KRW, the stock appears Overvalued by 41% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What ABL Bio Does
ABL Bio is a South Korean biotechnology company that discovers and develops antibody-based medicines. Its main work is creating biologic drug candidates, especially bispecific antibodies and antibody platforms designed to improve how cancer and neurological drugs reach their targets. It does not sell everyday consumer products; it sells drug development programs and licensing rights around its science.
- Headquarters
- Korea KR
- Employees
- 102
- IPO date
- Dec 19, 2018
ABL Bio has a narrow economic moat
ABL Bio Inc has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
ABL Bio Inc
Earnings Waterfall
ABL Bio Inc
The intrinsic value for ABL Bio Inc (298380) under the Base Case is 26 179.15 KRW.
Compared with the current market price of 44 250 KRW, the stock appears Overvalued by 41% .